Research and Clinical Trials

Title  

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Brief Description  

Overall survival: From randomization to date of death or last follow-up.

Who may be Eligible  

Please contact us for eligibility criteria.

Speciality/Disorder  

Lip, Oral Cavity and Pharynx

Status  

OPEN

Start Date  

11/08/2015

IRB Number  

00013418

Principal Investigator  

Moeller, Benjamin James

Contact Name  

Joey Armstrong

For More Information, Contact  Joey  , Armstrong
Phone:  980-442-2346 Fax:    
Email:  Joey.Armstrong@atriumhealth.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, NC 28204